• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,015.28 -1,312.91
( -1.70%)
Global Indices
Nasdaq
49,619.91 1.93
(0.00%)
Dow Jones
7,417.79 59.68
(0.81%)
Hang Seng
62,457.26 -256.39
(-0.41%)
Nikkei 225
10,269.73 36.66
(0.36%)
Forex
USD-INR
94.38 -0.30
(-0.31%)
EUR-INR
110.93 -0.26
(-0.23%)
GBP-INR
128.32 -0.39
(-0.30%)
JPY-INR
0.60 0.00
(-0.28%)

IPO Synopsis

  • YOU ARE HERE :
  • HOME breadcrum-arrow
  • IPO Synopsis

IPO

Goldline Pharmaceutical Ltd
  • Registered Office: 103 F-1 Leela Apartment Shilpa,HSG Society Shanidham Narendra, Nagpur - 440015, Maharashtra, India. Phone : +91 712 278 6666   Fax:
  • Email : info@goldlinepharma.in
  • Website :www.goldlinepharma.in
Initial public offer of upto 27,00,000 equity shares of face value of Rs. 10/- each ("Equity Shares") of Goldline Pharmaceutical Limited ("Issuer" or "The" "company") at an issue price of Rs.41-43 per equity share (including a share premium of Rs.31-33 per equity share) for cash, aggregating up to Rs.11.07-11.61 Crores ("Public Issue") out of which 1,38,000 equity shares of face value of Rs. 10/- each, at an issue price of Rs. 41-43 per equity share for cash, aggregating Rs. 0.57-0.59 Crores will be reserved for subscription by the market maker to the issue (the "Market Maker Reservation Portion"). The public issue less market maker reservation portion i.e. Issue of 25,62,000 equity shares of face value of Rs. 10/- each, at an issue price of Rs. 41-43 per equity share for cash, aggregating up to Rs. 10.50-11.02 Crores is hereinafter referred to as the "Net Issue". The public issue and net issue will constitute 28.13% and 26.69% respectively of the post-issue paid-up equity share capital of the company. Price Band is Rs. 41 to Rs. 43 per equity share of face value of Rs. 10/- each. The floor price is 4.1 times of the face value and the cap price is 4.3 times of the face value. Bids can be made for a minimum of Two lot and in multiples of 3,000 equity shares thereafter.
Issue
Opens On Closes On
12-May-26 14-May-26
Money Payable On
Application Allotment
41.00 0.00
Minimum Application for shares in Nos : 6000 Further Multiples of : 3000
Cr Lead Managers to the Issue
Project Cost (.Cr) 0.00 Cumulative Capital Private Limited
Project Financed through Current Offer (.Cr) 11.07  
Post Issue Equity Share Capital (.Cr) 9.60
Issue Price () 41.00
Projects
Repayment of all or a portion of certain outstanding borrowings availed by its company
General Corporate Purpose
Promoted By
Amol Laxmikant Mujumdar
Swapan Premprakash Khandelwal
Asha Swapan Khandelwal
Listing At
BSE - SME
Registrar to the Issue
No Data Available